SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Alfen N.V. (ABHBY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 40/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ABHBY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.49
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$10.07
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.03 |
$61.52M |
$1.14M |
1.8% |
| 2017 |
$0.05 |
$73.37M |
$1.72M |
2.3% |
| 2018 |
$-0.01 |
$100.18M |
$-263K |
-0.3% |
| 2019 |
$0.16 |
$143.08M |
$5.63M |
3.9% |
| 2020 |
$0.33 |
$189.01M |
$11.99M |
6.3% |
| 2021 |
$0.58 |
$249.68M |
$21.45M |
8.6% |
| 2022 |
$1.28 |
$439.88M |
$53.05M |
12.1% |
| 2023 |
$0.74 |
$504.48M |
$29.68M |
5.9% |
| 2024 |
$-0.62 |
$487.64M |
$-27.01M |
-5.5% |
| 2025 |
$0.00 |
$435.62M |
$-189K |
-0% |
